IVUS Guidance to Reduce Contrast in Coronary Angioplasty
MOZART
Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study
1 other identifier
interventional
83
1 country
1
Brief Summary
This study tests the hypothesis that ultrasound-guided PCI reduces contrast volume during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Nov 2012
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Posted
Study publicly available on registry
September 20, 2013
CompletedResults Posted
Study results publicly available
June 15, 2016
CompletedJune 15, 2016
May 1, 2016
10 months
January 1, 2013
May 6, 2016
May 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Volume of Iodine Contrast Used During Procedure
Total volume of iodine contrast administered during the index procedure.
Day 1
Secondary Outcomes (2)
Major Adverse Cardiac Events
30 days and 6 months
Incidence of Contrast-induced Nephropathy
7 days
Study Arms (2)
Angiography-guided PCI
NO INTERVENTIONAngiography-guided percutaneous coronary intervention
IVUS-guided PCI
ACTIVE COMPARATORIntravascular ultrasound guided percutaneous coronary intervention
Interventions
Intravascular ultrasound guided percutaneous coronary intervention
Eligibility Criteria
You may qualify if:
- Written informed consent
- Age \>=18 years
- Coronary artery disease scheduled for percutaneous intervention
- Technical feasibility for intravascular ultrasound to guide coronary angioplasty
- Increased risk for contrast-induced acute renal failure (e.g. age \> 80 years, female gender, diabetes, urgent or emergent procedure priority, diabetes, congestive heart failure, increased baseline serum creatinine, decreased calculated or measured creatinine clearance, intra-aortic balloon pumping, previous renal transplantation or single kidney)
You may not qualify if:
- Anticipated technical impossibility for intravascular ultrasound
- Unknown baseline renal function
- Baseline end-stage renal failure needing dialysis
- Acute renal failure with dynamic change in renal function at the time of index procedure
- Iodine contrast administration \<= 72 prior to index procedure
- Known allergy to iodine contrast
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heart Institute - InCor. University of Sao Paulo Medical School
São Paulo, São Paulo, 05403-000, Brazil
Related Publications (1)
Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, Spadaro AG, Perin MA, Filho AE, Takimura CK, Ribeiro E, Kalil-Filho R, Edelman ER, Serruys PW, Lemos PA. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014 Nov;7(11):1287-93. doi: 10.1016/j.jcin.2014.05.024. Epub 2014 Oct 15.
PMID: 25326742DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Patients were enrolled according to somewhat restricted criteria, which excluded patients with recent catheterization, using nephrotoxic agents, or with unstable or unknown renal function.
Results Point of Contact
- Title
- Dr. Pedro A. Lemos
- Organization
- Heart Institute (Incor)
Study Officials
- STUDY CHAIR
Pedro A Lemos, MD PhD
Heart Institute - InCor. University of Sao Paulo Medical School
- PRINCIPAL INVESTIGATOR
Paulo R Soares, MD PhD
Heart Institute - InCor. University of Sao Paulo Medical School
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
January 1, 2013
First Posted
September 20, 2013
Study Start
November 1, 2012
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
June 15, 2016
Results First Posted
June 15, 2016
Record last verified: 2016-05